OncoLab Email Formats

Biotechnology Research • Korea, Republic of • 1-10 Employees

Key Contact at OncoLab

Jongseong Kim

Chief Executive Officer

Company overview

Headquarters	Korea, Republic of
Website	oncolab.co.kr
NAICS	541714
Keywords	Cancer Immunotherapy, Tnbc, Angel, Drug Formulation And Delivery
Founded	2024
Employees	1-10

About OncoLab

OncolaB is an innovative bio-venture company that has developed the next-generation immune-oncology treatment platform ANGel, which possesses excellent drug delivery, efficacy, and sustainability. Founded in May 2024 by CEO Jongseong Kim, who has over 20 years of experience in nanogel research, the company received an investment of $500,000. Additionally, OncolaB was selected as a Deep Tech TIPS company by the Chungbuk Creative Economy Innovation Center, and secured further support of $1,500,000. Our company is developing treatment technologies for difficult-to-treat cancers, including triple-negative breast cancer and various solid tumors, with the following vision.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

OncoLab has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

OncoLab has never raised funding before.

Frequently asked questions

OncoLab is located in KR.

OncoLab was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

OncoLab has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at OncoLab

Jongseong Kim

Chief Executive Officer

4.8

40,000 users